Experiments were conducted to determine whether preemergence infection of potato sprouts by Phytophthora infestans occurs in the highland tropics of Ecuador. In three separate experiments in the field, P. infestans was identified on the preemerged sprouts of 49, 5, and 43% of tubers, respectively, which had been removed from soil prior to emergence. Tubers had been planted within 10 m of approximately 300-m plots with mature potato plants severely infected with late blight. Infection potential of potato sprouts also was evaluated in the greenhouse by applying 10-ml sporangial suspensions (50 and 250 sporangia/ml) daily for 10 days to the soil surface of pots planted with sprouted seed potato tubers. The daily inoculation rate of 50 sporangia/ml (15.9 × 10 sporangia/m) resulted in sprout infection in 100% of inoculated pots and roughly corresponded to the sporangial deposition accumulated over 24 h in the field. Deposition had been measured at 1 m from a severely infected potato plot. Our study demonstrated the potential for preemergence infection of potato sprouts by P. infestans in the highlands of Ecuador, where year-round aerial inoculum is present. Preemergence infection is consistent with high levels of disease sometimes seen in recently emerged potato fields. These experiments indicate a need to reconsider disease management approaches.

Download full-text PDF

Source
http://dx.doi.org/10.1094/PDIS-92-4-0569DOI Listing

Publication Analysis

Top Keywords

preemergence infection
16
potato sprouts
16
infection potato
12
potato
8
sprouts phytophthora
8
phytophthora infestans
8
highland tropics
8
tropics ecuador
8
severely infected
8
sprouts
5

Similar Publications

A trivalent mucosal vaccine encoding phylogenetically inferred ancestral RBD sequences confers pan-Sarbecovirus protection in mice.

Cell Host Microbe

December 2024

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO 63110, USA; Center for Vaccines and Immunity against Microbial Pathogens, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address:

The continued emergence of SARS-CoV-2 variants and the threat of future Sarbecovirus zoonoses have spurred the design of vaccines that can induce broad immunity against multiple coronaviruses. Here, we use computational methods to infer ancestral phylogenetic reconstructions of receptor binding domain (RBD) sequences across multiple Sarbecovirus clades and incorporate them into a multivalent adenoviral-vectored vaccine. Mice immunized with this pan-Sarbecovirus vaccine are protected in the upper and lower respiratory tracts against infection by historical and contemporary SARS-CoV-2 variants, SARS-CoV, and pre-emergent SHC014 and Pangolin/GD coronavirus strains.

View Article and Find Full Text PDF

First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial.

EBioMedicine

September 2024

National Centre for Infectious Diseases, Singapore; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Electronic address:

Article Synopsis
  • - A study evaluated the immune responses from two types of booster vaccinations (homologous BNT162b2 and heterologous mRNA-1273) in individuals who had previously received BNT162b2 and had not been infected with SARS-CoV-2.
  • - The results showed that those who received the heterologous booster had significantly higher antibody levels against wild-type SARS-CoV-2 six months after vaccination, and many participants experienced Omicron breakthrough infections regardless of the booster type.
  • - The findings suggest that while booster shots are beneficial, the immune response decreases significantly over time, highlighting the need for timely booster administration before infection surges. !*
View Article and Find Full Text PDF

The Host Range of in Western Canada.

Pathogens

May 2024

Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB T6G 2P5, Canada.

is associated with the root rot of many plant species, but knowledge of its impact on western Canadian field crops is limited. This study assessed the host range of this fungus and its effect on plant emergence, plant height, and shoot and root dry weights in repeated greenhouse experiments with wheat, barley, faba beans, peas, lentils, canola, lupine, and soybeans. Infection was confirmed via PCR, and principal component analysis determined the utility of different parameters in assessing host responses.

View Article and Find Full Text PDF

Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.

Cell Rep

January 2024

State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China; Shanghai Institute for Advanced Immunochemical Studies, School of Life Science and Technology, ShanghaiTech University, Shanghai, China; Guangzhou National Laboratory, Bio-Island, Guangzhou, China; Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, the Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, China. Electronic address:

Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the subgenus Sarbecovirus, members of which share high sequence similarity. Herein, we report one sarbecovirus antibody, 5817, which has broad-spectrum neutralization capacity against SARS-CoV-2 variants of concern (VOCs) and SARS-CoV, as well as related bat and pangolin viruses.

View Article and Find Full Text PDF

Multiple coronaviruses (CoVs) can cause respiratory diseases in humans. While prophylactic vaccines designed to prevent infection are available for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), incomplete vaccine efficacy, vaccine hesitancy, and the threat of other pathogenic CoVs for which vaccines do not exist have highlighted the need for effective antiviral therapies. While antiviral compounds targeting the viral polymerase and protease are already in clinical use, their sensitivity to potential resistance mutations as well as their breadth against the full range of human and preemergent CoVs remain incompletely defined.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!